GRPH Insider Trading Activity and SEC Form 4 Filings
GRPH insider trading summary
No open-market insider purchases or sales of Graphite Bio, Inc. (GRPH) have been reported on SEC Form 4 in the past 12 months.
Latest GRPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 12, 2022 | Samsara BioCapital, L.P. | 10% Owner | Buy | $1.4M (350,000 @ $4.08) |
| Apr 12, 2022 | Srinivas Akkaraju | 10% Owner | Buy | $1.4M (350,000 @ $4.08) |
| Apr 11, 2022 | Phil Gutry | Chief Business Officer | Buy | $20K (5,000 @ $4.01) |
| Apr 11, 2022 | Srinivas Akkaraju | 10% Owner | Buy | $303K (74,464 @ $4.07) |
| Apr 11, 2022 | Samsara BioCapital, L.P. | 10% Owner | Buy | $303K (74,464 @ $4.07) |
| Jan 24, 2022 | Samsara BioCapital, L.P. | 10% Owner | Buy | $200K (23,000 @ $8.70) |
| Jan 24, 2022 | Srinivas Akkaraju | 10% Owner | Buy | $200K (23,000 @ $8.70) |
| Jan 21, 2022 | Srinivas Akkaraju | 10% Owner | Buy | $899K (100,000 @ $8.99) |
| Jan 21, 2022 | Samsara BioCapital, L.P. | 10% Owner | Buy | $899K (100,000 @ $8.99) |
| Jan 20, 2022 | Samsara BioCapital, L.P. | 10% Owner | Buy | $384K (43,105 @ $8.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.